AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 27537508 — intervention group
Group type: EXPERIMENTAL
Intervention: Turning Point
Number of subjects: 80
Study 27537508 — intervention group
Group type: COMPARATOR
Intervention: Standard of Care
Number of subjects: 80
Study 25239491 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral intramuscular administration of cytokine‐mobilized CD133+ cells (50-400 million cells)
Number of subjects: 10
Study 25239491 — intervention group
Group type: COMPARATOR
Intervention: Normal saline injections, sham leukapheresis, and intramuscular injection of placebo buffered solution
Number of subjects: 10
Study 22500703 — intervention group
Group type: EXPERIMENTAL
Intervention: Posturographic evaluation at home
Number of subjects: 35
Study 22500703 — intervention group
Group type: COMPARATOR
Intervention: Posturographic evaluation in hospital
Number of subjects: 35
Study 20601351 — intervention group
Group type: COMPARATOR
Intervention: Resource-based system
Number of subjects: 75
Study 20601351 — intervention group
Group type: EXPERIMENTAL
Intervention: Task-based system
Number of subjects: 75
Study 18819393 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HBO) for 3 days (twice a day) using a monoplace chamber under pressures of 1.7‐1.9 ATA
Number of subjects: 44
Study 18819393 — intervention group
Group type: COMPARATOR
Intervention: Standardized treatment protocol (Control)
Number of subjects: 44
Study 18819393 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HBO)
Number of subjects: 44
Study 16204433 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketanserin (40 mg)
Number of subjects: 10
Study 16204433 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 12012623 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral estradiol 4 mg/day (group A)
Number of subjects: 29
Study 12012623 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral estradiol 6 mg/day (group B)
Number of subjects: 29
Study 10631416 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol 2 g through a nasogastric tube
Number of subjects: 20
Study 10631416 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal paracetamol 2 g
Number of subjects: 20
Study 10631416 — intervention group
Group type: COMPARATOR
Intervention: Standard doses of paracetamol (6 g/day) on day 1 after cardiac surgery
Number of subjects: 20
Study 8745039 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 micrograms of DDAVP
Number of subjects: 0
Study 8745039 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 0
Study 2401754 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol at peak estimated blood alcohol concentration (Est.BAC) of 0.07 gm/dL
Number of subjects: 0
Study 2401754 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol at peak Est.BAC of 0.1 gm/dL
Number of subjects: 0
Study 2401754 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol at peak Est.BAC of 0.14 gm/dL
Number of subjects: 0
Study 2401754 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 7272396 — intervention group
Group type: EXPERIMENTAL
Intervention: High need for power subjects
Number of subjects: 0
Study 7272396 — intervention group
Group type: EXPERIMENTAL
Intervention: Low need for power subjects
Number of subjects: 0
Study 31833441 — intervention group
Group type: EXPERIMENTAL
Intervention: COPD patients
Number of subjects: 90
Study 31833441 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal lung function)
Number of subjects: 90
Study 30575239 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy with irinotecan (60 mg/m2 on days 1 and 8) and nedaplatin (80 mg/m2 on day 1 of every 21‐day cycle) followed by radical hysterectomy and adjuvant chemotherapy.
Number of subjects: 32
Study 28898131 — intervention group
Group type: EXPERIMENTAL
Intervention: New solid nodules < 4 mm
Number of subjects: 25002
Study 28898131 — intervention group
Group type: EXPERIMENTAL
Intervention: New solid nodules 4 to < 6 mm
Number of subjects: 25002
Study 28898131 — intervention group
Group type: EXPERIMENTAL
Intervention: New solid nodules 6 to < 8 mm
Number of subjects: 25002
Study 28898131 — intervention group
Group type: EXPERIMENTAL
Intervention: New solid nodules ≥ 20 mm
Number of subjects: 25002
Study 28898131 — intervention group
Group type: EXPERIMENTAL
Intervention: New solid nodules overall
Number of subjects: 25002
Study 28898131 — intervention group
Group type: EXPERIMENTAL
Intervention: Cancers associated with new nodules
Number of subjects: 25002
Study 25342648 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovenous laser ablation
Number of subjects: 449
Study 25342648 — intervention group
Group type: COMPARATOR
Intervention: High ligation and stripping
Number of subjects: 449
Study 25342648 — intervention group
Group type: COMPARATOR
Intervention: High ligation/endovenous laser ablation
Number of subjects: 449
Study 25087600 — intervention group
Group type: EXPERIMENTAL
Intervention: Vortioxetine (10-20 mg/day)
Number of subjects: 493
Study 25087600 — intervention group
Group type: COMPARATOR
Intervention: Agomelatine (25-50 mg/day)
Number of subjects: 493
Study 25087600 — intervention group
Group type: EXPERIMENTAL
Intervention: Vortioxetine
Number of subjects: 493
Study 25087600 — intervention group
Group type: EXPERIMENTAL
Intervention: Vortioxetine and Agomelatine
Number of subjects: 493
Study 22079390 — intervention group
Group type: COMPARATOR
Intervention: Nutraceuticals (coenzyme Q(10), RRR‐α‐tocopherol, selenium aspartate, and L‐methionine) with cryotherapy for HPV warts
Number of subjects: 157
Study 22079390 — intervention group
Group type: COMPARATOR
Intervention: Nutraceuticals (coenzyme Q(10), RRR‐α‐tocopherol, selenium aspartate, and L‐methionine) with acyclovir for herpes infections
Number of subjects: 157
Study 22079390 — intervention group
Group type: COMPARATOR
Intervention: Nutraceuticals (coenzyme Q(10), RRR‐α‐tocopherol, selenium aspartate, and L‐methionine)
Number of subjects: 157
Study 19671308 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucagon injection
Number of subjects: 68
Study 19671308 — intervention group
Group type: COMPARATOR
Intervention: Normal controls (NC)
Number of subjects: 68
Study 17498005 — intervention group
Group type: EXPERIMENTAL
Intervention: KRN321 (darbepoetin alfa) administered at extended dose intervals (once per week or once every two weeks)
Number of subjects: 513
Study 17498005 — intervention group
Group type: COMPARATOR
Intervention: rHuEPO (recombinant human erythropoietin)
Number of subjects: 513
Study 15170885 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g/m2 MTX as a 24-hr infusion
Number of subjects: 30
Study 15170885 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g/m2 MTX as a 24-hr infusion
Number of subjects: 30
Study 11587466 — intervention group
Group type: COMPARATOR
Intervention: Classical SDD regimen (tobramycin 80 mg, polymyxin E 100 mg, amphotericin B 500 mg)
Number of subjects: 223
Study 11587466 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified SDD regimen with mupirocin (2% mupirocin ointment applied four times daily in nostrils and modified oral paste)
Number of subjects: 223
Study 11587466 — intervention group
Group type: COMPARATOR
Intervention: Classical SDD regimen
Number of subjects: 223
Study 11587466 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified SDD regimen with mupirocin
Number of subjects: 223
Study 9838776 — intervention group
Group type: EXPERIMENTAL
Intervention: Spray group
Number of subjects: 98
Study 9838776 — intervention group
Group type: COMPARATOR
Intervention: Double layer group
Number of subjects: 98
Study 7861710 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous ambulatory peritoneal dialysis (CAPD)
Number of subjects: 53
Study 7861710 — intervention group
Group type: COMPARATOR
Intervention: Normolipidemic subjects (cholesterol < 6.5 mmol/liter, triglycerides < 2.0 mmol/liter)
Number of subjects: 53
Study 7861710 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperlipidemic subjects
Number of subjects: 53
Study 7861710 — intervention group
Group type: EXPERIMENTAL
Intervention: All renal patients combined
Number of subjects: 53
Study 2510275 — intervention group
Group type: EXPERIMENTAL
Intervention: Rioprostil, 300 micrograms q.d.s.
Number of subjects: 0
Study 2510275 — intervention group
Group type: EXPERIMENTAL
Intervention: Rioprostil, 100 micrograms q.d.s.
Number of subjects: 0
Study 2510275 — intervention group
Group type: COMPARATOR
Intervention: Placebo q.d.s.
Number of subjects: 0
Study 782468 — intervention group
Group type: EXPERIMENTAL
Intervention: sodium pentosan polysulphate/nicotinic acid combination (Compuron)
Number of subjects: 60
Study 31395363 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrative Positive Psychological Intervention for Depression (IPPI-D)
Number of subjects: 128
Study 31395363 — intervention group
Group type: COMPARATOR
Intervention: Cognitive-Behavioral Therapy (CBT)
Number of subjects: 128
Study 28292340 — intervention group
Group type: EXPERIMENTAL
Intervention: Phentolamine mesylate (Oraverse)
Number of subjects: 150
Study 28292340 — intervention group
Group type: COMPARATOR
Intervention: Sham injection
Number of subjects: 150
Study 26178497 — intervention group
Group type: EXPERIMENTAL
Intervention: Cecal ligation puncture and rosiglitazone group (group CLP+ROSI)
Number of subjects: 96
Study 26178497 — intervention group
Group type: COMPARATOR
Intervention: Cecal ligation puncture group (group CLP)
Number of subjects: 96
Study 26178497 — intervention group
Group type: COMPARATOR
Intervention: Sham and rosiglitazone group (group Sham+ROSI)
Number of subjects: 96
Study 26178497 — intervention group
Group type: COMPARATOR
Intervention: Sham group (group Sham)
Number of subjects: 96
Study 22692105 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm-up program with functional exercises (WPS)
Number of subjects: 121
Study 22692105 — intervention group
Group type: COMPARATOR
Intervention: Warm-up program without functional exercises (NWP)
Number of subjects: 121
Study 22692105 — intervention group
Group type: EXPERIMENTAL
Intervention: Change-of-direction sprints with functional exercises (WPS)
Number of subjects: 121
Study 22692105 — intervention group
Group type: COMPARATOR
Intervention: Change-of-direction sprints without functional exercises (NWP)
Number of subjects: 121
Study 21375164 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual vacuum aspiration (MVA)
Number of subjects: 176
Study 21375164 — intervention group
Group type: COMPARATOR
Intervention: Electrical vacuum aspiration (EVA)
Number of subjects: 176
Study 18070234 — intervention group
Group type: EXPERIMENTAL
Intervention: FICE system with low magnification
Number of subjects: 63
Study 18070234 — intervention group
Group type: EXPERIMENTAL
Intervention: FICE system with high magnification
Number of subjects: 63
Study 18070234 — intervention group
Group type: COMPARATOR
Intervention: Standard colonoscopy
Number of subjects: 63
Study 18070234 — intervention group
Group type: COMPARATOR
Intervention: Conventional chromoendoscopy with indigo carmine
Number of subjects: 63
Study 16313883 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist-initiated telephone sessions
Number of subjects: 100
Study 16313883 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist-initiated email sessions
Number of subjects: 100
Study 16313883 — intervention group
Group type: EXPERIMENTAL
Intervention: Client-initiated contact
Number of subjects: 100
Study 16313883 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 100
Study 15619967 — intervention group
Group type: EXPERIMENTAL
Intervention: Leucocyte filtration of residual heart-lung machine blood
Number of subjects: 50
Study 15619967 — intervention group
Group type: COMPARATOR
Intervention: Control group (unfiltered blood)
Number of subjects: 50
Study 11086616 — intervention group
Group type: EXPERIMENTAL
Intervention: Abbreviated questionnaire
Number of subjects: 146
Study 11086616 — intervention group
Group type: EXPERIMENTAL
Intervention: Monetary incentive
Number of subjects: 146
Study 11086616 — intervention group
Group type: COMPARATOR
Intervention: SF-36 Health Status Survey
Number of subjects: 146
Study 11086616 — intervention group
Group type: COMPARATOR
Intervention: SF-36 plus a form assessing amount of treatment received
Number of subjects: 146
Study 9352457 — intervention group
Group type: EXPERIMENTAL
Intervention: Multispectral maps
Number of subjects: 16
Study 9352457 — intervention group
Group type: COMPARATOR
Intervention: Conventional spin-echo images
Number of subjects: 16
Study 1549886 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical suture and cast immobilisation for six weeks
Number of subjects: 60
Study 1549886 — intervention group
Group type: COMPARATOR
Intervention: Cast immobilisation alone for six weeks
Number of subjects: 60
Study 3903733 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet and smoking advice
Number of subjects: 1232
Study 3903733 — intervention group
Group type: EXPERIMENTAL
Intervention: Antismoking advice
Number of subjects: 1232
Study 30463827 — intervention group
Group type: EXPERIMENTAL
Intervention: Xiaozhong Zhitong Decoction
Number of subjects: 160
Study 26879829 — intervention group
Group type: EXPERIMENTAL
Intervention: Health literacy, quality of the provider interaction, perceived communication skills, and behavioral activation
Number of subjects: 109
Study 26879829 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of the provider interaction, perceived communication skills, and behavioral activation
Number of subjects: 109
Study 23943112 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training (ankle dorsiflexor muscles) three times per week for 2 weeks
Number of subjects: 60
Study 23943112 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 60
Study 23086244 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional management plus intravenous infusion of octreotide, 50 μg/h for 72 hours (obese-C+O)
Number of subjects: 243
Study 23086244 — intervention group
Group type: COMPARATOR
Intervention: Conventional management (obese-C)
Number of subjects: 243
Study 20497150 — intervention group
Group type: EXPERIMENTAL
Intervention: GlideScope
Number of subjects: 42
Study 20497150 — intervention group
Group type: COMPARATOR
Intervention: Direct laryngoscopy (Macintosh)
Number of subjects: 42
Study 18568274 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based interventions delivered by lady health workers (LHWs) and traditional birth attendants (Dais) in intervention villages.
Number of subjects: 138600
Study 15752371 — intervention group
Group type: EXPERIMENTAL
Intervention: Amyl nitrite (0.2 ml inhaled for 30 s)
Number of subjects: 21
Study 15752371 — intervention group
Group type: EXPERIMENTAL
Intervention: Glyceryl trinitrate (0.5 mg for 3 min)
Number of subjects: 21
Study 15752371 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 21
Study 12452302 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicorandil (100 microg/kg)
Number of subjects: 24
Study 12452302 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 24
Study 10730758 — intervention group
Group type: EXPERIMENTAL
Intervention: VML 295 (LY-293111) 200 mg twice daily for 8 weeks
Number of subjects: 35
Study 10730758 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 8 weeks
Number of subjects: 35
Study 10730758 — intervention group
Group type: EXPERIMENTAL
Intervention: VML 295 (LY-293111)
Number of subjects: 35
Study 10730758 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 9377614 — intervention group
Group type: EXPERIMENTAL
Intervention: Mometasone furoate 0.1%-salicylic acid 5% ointment, applied twice daily for 21 days
Number of subjects: 40
Study 9377614 — intervention group
Group type: COMPARATOR
Intervention: Fluocinonide 0.05% ointment, applied twice daily for 21 days
Number of subjects: 40
Study 1332095 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (2 micrograms/kg)
Number of subjects: 72
Study 1332095 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 72
Study 1332095 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 72
Study 3873372 — intervention group
Group type: COMPARATOR
Intervention: Aspirin (3.9 g/day)
Number of subjects: 7
Study 3873372 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (1.95 g/day) with Acetaminophen (1.95 g/day)
Number of subjects: 7
Study 3873372 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (2.6 g/day) with Acetaminophen (2.6 g/day)
Number of subjects: 7
Study 31640683 — intervention group
Group type: EXPERIMENTAL
Intervention: Poor patients
Number of subjects: 45
Study 31640683 — intervention group
Group type: EXPERIMENTAL
Intervention: Rich patients
Number of subjects: 45
Study 31640683 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients without socio-economic markers
Number of subjects: 45
Study 30342855 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyurea (HU+)
Number of subjects: 34
Study 30342855 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium Nitroprusside (SNP)
Number of subjects: 34
Study 30342855 — intervention group
Group type: COMPARATOR
Intervention: Control (HU-)
Number of subjects: 34
Study 27255504 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted intervention including academic detailing, medicine review with web-based pharmaceutical treatment algorithms, and tailored patient information leaflets.
Number of subjects: 196
Study 27255504 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted intervention
Number of subjects: 196
Study 27255504 — intervention group
Group type: COMPARATOR
Intervention: Usual care with simple, patient-level PIP feedback (Control)
Number of subjects: 196
Study 24712840 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol
Number of subjects: 180
Study 24712840 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180
Study 22488488 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention arm with observed compliance during the trial and resumed population screening.
Number of subjects: 0
Study 22488488 — intervention group
Group type: COMPARATOR
Intervention: Contaminated control arm with observed contamination during the trial and resumed population screening.
Number of subjects: 0
Study 22488488 — intervention group
Group type: COMPARATOR
Intervention: Uncontaminated control arm that discontinued screening upon entry.
Number of subjects: 0
Study 20515625 — intervention group
Group type: EXPERIMENTAL
Intervention: Interventional training program for primary care physicians on beta-blocker use
Number of subjects: 627
Study 20515625 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training program)
Number of subjects: 627
Study 20515625 — intervention group
Group type: EXPERIMENTAL
Intervention: Interventional training group
Number of subjects: 627
Study 18931880 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive postoperative rehabilitation program for women undergoing SNB
Number of subjects: 89
Study 18931880 — intervention group
Group type: COMPARATOR
Intervention: No rehabilitation for women undergoing SNB
Number of subjects: 89
Study 18931880 — intervention group
Group type: COMPARATOR
Intervention: Women undergoing ALND
Number of subjects: 89
Study 15781762 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide, 32 mug/d per nostril
Number of subjects: 61
Study 15781762 — intervention group
Group type: COMPARATOR
Intervention: Desloratadine, 5 mg/d
Number of subjects: 61
Study 12540404 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-fortified salt (DFS) containing 25 micro g iodine/g salt and 1 mg iron/g salt
Number of subjects: 377
Study 12540404 — intervention group
Group type: COMPARATOR
Intervention: Iodized salt
Number of subjects: 377
Study 10650538 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette smoking (two standard cigarettes)
Number of subjects: 24
Study 10650538 — intervention group
Group type: COMPARATOR
Intervention: Sham smoking
Number of subjects: 24
Study 8707361 — intervention group
Group type: EXPERIMENTAL
Intervention: Amphotericin B (AMB) 1 mg/kg bw/day for 20 days
Number of subjects: 288
Study 8707361 — intervention group
Group type: EXPERIMENTAL
Intervention: Amphotericin B (AMB) 0.75 mg/kg bw/day for 20 days
Number of subjects: 288
Study 8707361 — intervention group
Group type: EXPERIMENTAL
Intervention: Amphotericin B (AMB) 0.5 mg/kg bw/day for 20 days
Number of subjects: 288
Study 30355551 — intervention group
Group type: EXPERIMENTAL
Intervention: eHealth intervention-only
Number of subjects: 82
Study 30355551 — intervention group
Group type: EXPERIMENTAL
Intervention: eHealth intervention-occupational physician
Number of subjects: 82
Study 30355551 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (CAU)
Number of subjects: 82
Study 26967690 — intervention group
Group type: EXPERIMENTAL
Intervention: Anastrozole (1 mg daily) for 6 weeks
Number of subjects: 17
Study 26967690 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 6 weeks
Number of subjects: 17
Study 24655490 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 green kiwifruit a day plus a healthy diet
Number of subjects: 85
Study 24655490 — intervention group
Group type: COMPARATOR
Intervention: Healthy diet alone
Number of subjects: 85
Study 22420776 — intervention group
Group type: COMPARATOR
Intervention: One-step self-etch adhesive systems (Clearfil S(3) Bond, AdheSE One, Adper Easy One) with aging condition 24 h in water (Control)
Number of subjects: 72
Study 22420776 — intervention group
Group type: EXPERIMENTAL
Intervention: One-step self-etch adhesive systems (Clearfil S(3) Bond, AdheSE One, Adper Easy One) with aging condition 6 months of water storage (WS)
Number of subjects: 72
Study 22420776 — intervention group
Group type: EXPERIMENTAL
Intervention: One-step self-etch adhesive systems (Clearfil S(3) Bond, AdheSE One, Adper Easy One) with aging condition 10,000 thermocycles (TC)
Number of subjects: 72
Study 22420776 — intervention group
Group type: EXPERIMENTAL
Intervention: Clearfil S(3) Bond
Number of subjects: 72
Study 20631413 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 weeks of moderate-intensity endurance training
Number of subjects: 12
Study 20631413 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance training
Number of subjects: 12
Study 16516511 — intervention group
Group type: EXPERIMENTAL
Intervention: Loratadine (10mg daily)
Number of subjects: 15
Study 16516511 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast (10mg daily)
Number of subjects: 15
Study 16516511 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 16269590 — intervention group
Group type: EXPERIMENTAL
Intervention: TIMI flow grade <= 1
Number of subjects: 118
Study 16269590 — intervention group
Group type: COMPARATOR
Intervention: TIMI flow grade > 1
Number of subjects: 118
Study 12011706 — intervention group
Group type: EXPERIMENTAL
Intervention: Pneumatic compression
Number of subjects: 50